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The presence of foreign DNA in the cytosol of
mammalian cells elicits a potent antiviral interferon
response. Recently, cytosolic DNA was proposed
to induce the synthesis of cyclic GMP-AMP (cGAMP)
upon binding to an enzyme called cGAMP synthase
(cGAS). cGAMP activates an interferon response by
binding to a downstream receptor called STING.
Here, we identify natural variants of human STING
(hSTING) that are poorly responsive to cGAMP
yet, unexpectedly, are normally responsive to DNA
and cGAS signaling. We explain this paradox by
demonstrating that the cGAS product is actually a
noncanonical cyclic dinucleotide, cyclic [G(20-50)
pA(30-50)p], which contains a single 20-50 phospho-
diester bond. Cyclic [G(20-50)pA(30-50)p] potently
activates diverse hSTING receptors and, therefore,
may be a useful adjuvant or immunotherapeutic.
Our results indicate that hSTING variants have
evolved to distinguish conventional (30-50) cyclic
dinucleotides, known to be produced mainly by
bacteria, from the noncanonical cyclic dinucleotide
produced by mammalian cGAS.
INTRODUCTION
Recognition of pathogen-derived nucleic acid is a major mecha-
nism by which innate immune responses are initiated in
mammals (Barbalat et al., 2011). Several families of germ-line-
encoded nucleic acid sensors have been described, including
the Toll-like receptors and RIG-I-like receptors (Palm and Medz-
hitov, 2009; Takeuchi and Akira, 2010). Upon binding nucleic
acids, these sensors initiate signaling cascades that lead to the
production of cytokines and other immune effector proteins
that provide host defense.CThe cytosolic presence of foreign double-stranded DNA
(dsDNA) triggers a potent antiviral response dominated by the
production of type I interferons (IFNs) (Ishii et al., 2006; Stetson
and Medzhitov, 2006). An endoplasmic-reticulum-resident host
protein called stimulator of IFN genes (STING; also called
TMEM173, MITA, ERIS, and MPYS) was shown to be required
for IFN response to cytosolic dsDNA (Ishikawa and Barber,
2008; Ishikawa et al., 2009; Sun et al., 2009; Zhong et al.,
2008). Bacterially derived second messenger molecules called
cyclic dinucleotides (CDNs) can also induce an IFN response
(McWhirter et al., 2009) that depends on STING (Jin et al.,
2011a; Sauer et al., 2011). CDNs are secreted or released into
the cytosol by certain bacterial pathogens (Barker et al., 2013;
Woodward et al., 2010) and bind directly to STING (Burdette
et al., 2011). Previously, we identified a mutant allele of mouse
STING (mSTING), encoding an alanine in place of arginine 231
(R231A), that abolished responsiveness to CDNs but did not
appreciably affect the IFN response to cytosolic dsDNA (Bur-
dette et al., 2011). Thus, although the IFN responses to both
cytosolic CDNs and dsDNA require STING, the responses to
these chemically distinct ligands can be genetically uncoupled.
Two recent papers (Sun et al., 2013; Wu et al., 2013) unified
our understanding of the cytosolic response to CDNs and DNA
by proposing that the cytosolic presence of dsDNA leads
to the production of a CDN, cyclic GMP-AMP (cGAMP), by a
DNA-dependent sensor enzyme called cGAMP synthase
(cGAS). cGAMP was shown to bind and activate STING, but it
remained unclear how the mSTING R231A mutant could still
initiate responses to dsDNA while lacking responsiveness to
CDNs. Therefore, we sought to investigate the mechanism by
which cGAS activates STING.
RESULTS AND DISCUSSION
Our previous work (Burdette et al., 2011; Sauer et al., 2011)
focused primarily on mSTING, and it is not yet clear whether all
human STING (hSTING) variants can respond to CDNs (Conlon
et al., 2013; Jin et al., 2011b). In agreement with previous reportsell Reports 3, 1355–1361, May 30, 2013 ª2013 The Authors 1355
Figure 1. Variable Responsiveness of
hSTING Variants to Cyclic Dinucleotides
Maps to Arginine 232
(A) THP-1 cells were transduced with vectors
encoding an shRNA targeting STING or a control
shRNA. Then, cells were stimulated with cyclic
di-GMP (cdG), dsDNA, cyclic di-AMP (cdA),
polyinosine:cytosine (p(I:C)), or Sendai virus, and
the induction of human interferon-b messenger
RNA was assessed by qRT- PCR.
(B) Western blotting confirmed that knockdown of
STING was effective.
(C) HEK 293T cells were transfected with the
indicated amounts of various mouse (m) or
human (h) STING expression plasmid and then
stimulated 6 hr later by transfection with syn-
thetic cdG (5 mM). GT denotes the null
I199N allele of STING from Goldenticket (Gt)
mice. STING activation was assessed with the
use of a cotransfected IFNb-luciferase reporter
construct.
(D) Gt (STING-null) macrophages were trans-
duced with retroviral vectors encoding the
indicated STING alleles and were stimulated
48 hr later by transfection with cdG (5 mM) or
dsDNA 70-mer oligonucleotide (0.5 mg/ml). IFNb
induction was measured by qRT-PCR. ND, not
detected.
(E) Binding assay of STING to 32P-cdG.
STING proteins were expressed in HEK 293T
cells, and cell lysates were subjected to UV
crosslinking with 32P-cdG and resolved by
SDS-PAGE. Binding was quantified by autoradiography. Western blots of cell lysates with an anti-STING polyclonal antibody confirmed similar expression of
the various STING proteins.
(F) Responsiveness of mSTING to cGAMP is affected by mutations of R231. The indicated mutants were tested as in (C).
Data are representative of at least three independent experiments and are presented as the mean. Error is represented as SEM. ***p < 0.0001, **p < 0.005.
See also Figure S1.(Sun et al., 2013;Wu et al., 2013), we found that the humanTHP-1
cell line responds robustly to CDNs in a manner dependent on
STING (Figures 1A and 1B). We cloned an hSTING allele from
THP-1 cells and compared its amino acid sequence to the previ-
ously widely studied reference allele (NP_938023.1, denoted
here as hSTINGREF) (Ishikawa and Barber, 2008) (Figure S1).
We found that hSTINGREF and hSTINGTHP-1 differ at four amino
acid positions. Notably, hSTINGTHP-1 encodes an arginine (R)
at position 232, corresponding to R231 in mSTING; in contrast,
hSTINGREF encodes a histidine (H) at position 232. We decided
to test the functionality of individual STING alleles by expressing
these alleles in human embryonic kidney (HEK) 293T cells that
lack endogenous STING. As previously observed (Burdette
et al., 2011), overexpression of mSTING in HEK 293T cells in-
duces ligand-independent activation of an IFNb-luciferase
reporter construct, but expression of lower amounts of mSTING
renders HEK 293T cells responsive to CDNs (Figure 1C). Simi-
larly, HEK 293T cells overexpressing hSTINGREF spontaneously
activated an IFNb-luciferase reporter (Figure 1C). However, un-
like mSTING, cells expressing low amounts of hSTINGREF were
poorly responsive to stimulation with cyclic di-GMP (cdG) (Fig-
ure 1C). In contrast, cells expressing hSTINGTHP-1 were respon-
sive to cdG and exhibited 10-fold induction of the IFN-lucif-
erase reporter, similar to what is seen with mSTING (Figure 1C).1356 Cell Reports 3, 1355–1361, May 30, 2013 ª2013 The AuthorsHEK 293T cells expressing STING do not respond to stimula-
tion by dsDNA, presumably because of the lack of expression of
cGAS (Sun et al., 2013) or perhaps other dsDNA sensors. There-
fore, to test whether the hSTING variants could respond to
dsDNA stimulation, we transduced cGAS+ STING-null (Golden-
ticket) (Sauer et al., 2011) macrophages with hSTING expression
vectors. Even the hSTINGREF variant that responds poorly to
CDNs conferred responsiveness to dsDNA (Figure 1D). There-
fore, hSTINGREF phenocopies mSTINGR231A and uncouples
responsiveness to CDNs and dsDNA (Burdette et al., 2011).
Consistent with the above results with hSTING variants, an
R231H mutant of mSTING responded poorly to CDNs, as did
R232A or R232H variants of hSTINGTHP-1 (Figure S2A). Thus,
R231 and R232 appear critical for responsiveness to CDNs in
mSTING and hSTING, respectively. Introduction of an H232R
mutation in hSTINGREF was not sufficient to restore responsive-
ness to CDNs; indeed, we found that a second substitution
(G230A) was also required (Figure S3). All the variant STING
alleles that we tested bound cdG (Figures 1E and S2B) (Huang
et al., 2012; Ouyang et al., 2012; Yin et al., 2012), consistent
with the fact that residues 230 and 232 are located in loops
that cover, but do not form, the CDN binding pocket.
Importantly, mSTINGR231A also failed to respond to chemically
synthesized cGAMP (Figure 1F) (Kellenberger et al., 2013). This
Figure 2. STING Variants Are Responsive to
cGAS
(A) HEK 293T cells were transfected with the
indicated STING alleles and with human and
mouse cGAS (WT and GS > AA mutants) (Sun
et al., 2013) as indicated. STING activation was
assessed by a cotransfected IFNb-luciferase re-
porter construct.
(B) HEK 293T cells were transfected with the
indicated STING alleles and with a mammalian
expression vector encoding a cGAMP synthase
(DncV) from V. cholerae. STING activation was
assessed as in (A).
(C) In vitro enzymatically generated products of
rWspR, rDncV, and rcGAS were transfected into
digitonin permeabilized HEK 293T cells express-
ing the indicated mouse and hSTING proteins.
Chemically synthesized cdG and cGAMP were
included as controls. STING activation was
assessed as in (A) and (B). Data are representative
of at least three independent experiments and are
presented as mean. Error is represented as SEM.
See also Figures S2 and S3.observation raised the question of whether R231A or R232H
variants of STING would respond to the cGAS enzyme that is
believed to activate STING via the production of cGAMP. Sur-
prisingly, we found that human or mouse cGAS expression
robustly activated hSTINGREF and mSTINGR231A variants (Fig-
ure 2A). We considered several explanations for this puzzling
result. One possibility is that the response was due simply to
the overexpression of the cGAMP synthase in mammalian cells;
however, overexpression of DncV, a bacterial cGAMP synthase
from V. cholerae (Davies et al., 2012), did not activate hSTINGREF
or mSTINGR231A but did activate wild-type mSTING and
hSTINGTHP-1 (Figure 2B). An alternative hypothesis is that
cGAS might activate STING by a direct physical interaction
and in a manner independent of cGAMP production. However,
this explanation also appears to be incorrect. As previously
demonstrated (Sun et al., 2013), the overexpression of catalyti-
cally deadmutantsof humanormousecGAS (GS>AA;Figure2A)
failed to activate STING variants, arguing that cGAS signaling
depends on the production of a second messenger rather than
on a direct physical interaction with STING. To confirm this inter-
pretation, we produced the enzymatic product of cGAS by
providing ATP, guanosine triphosphate (GTP), and dsDNA to
purified recombinant cGAS in vitro. As a negative control, dsDNA
(required to stimulate cGAS activity) was omitted from a parallel
reaction. Then, the resulting cGAS products were purified andCell Reports 3, 1355–136transfected into HEK 293T cells ex-
pressing STING variants. In contrast to
synthetic cGAMP, the cGAS product
was able to activate hSTINGREF and
mSTINGR231A (Figure 2C). This experi-
ment provides evidence against a model
in which cGAS activates hSTINGREF via
a direct physical interaction.
cGAS is structurally homologous to
another innate immune sensor calledoligoadenylate synthase that produces a noncanonical oligoa-
denylate polymer containing 20-50 phosphodiester bonds (Kran-
zusch et al., 2013; Sun et al., 2013). Therefore, we hypothesized
that cGASmight not produce a canonical CDN as previously pro-
posed (Sun et al., 2013; Wu et al., 2013) but, instead, might pro-
duce a CDN containing 20-50 phosphodiester bond(s) that could
stimulate variant STING alleles. Such a noncanonical CDNwould
have a mass identical to the canonical 30-50 phosphodiester-
linked CDN, and, thus, the two products would not have been
easy to distinguish by previously published mass spectrometric
analyses of the cGAS product (Sun et al., 2013; Wu et al., 2013).
We tested our hypothesis by providing radiolabelled a-32P-GTP
or a-32P-ATP to recombinant purified cGAS or V. cholerae DncV
and analyzing the products by thin-layer chromatography (TLC).
As reported previously, DncV can produce some cyclic di-AMP
(cdA) when provided with only ATP and some cdG when pro-
vided with only GTP but prefers to make cGAMP when provided
with both ATP and GTP (Davies et al., 2012) (Figure 3A). cGAS
requires both ATP andGTP substrates, and the resulting product
migrates significantly differently than any of the canonical CDNs
produced by DncV, suggesting that cGAS produces a nonca-
nonical CDN (Figure 3A).
We analyzed the cGAS and DncV products by specific
nuclease digestion. The cGAS product is partially cleaved by
nuclease P1, which selectively digests 30-50 phosphodiester1, May 30, 2013 ª2013 The Authors 1357
Figure 3. cGAS Produces a Noncanonical
Cyclic Dinucleotide
(A) Purified recombinant WspR, DncV, or cGAS
were mixed with a-32P-ATP or a-32P-GTP and the
indicated unlabeled nucleotides. Reactions were
mixed with TLC running buffer, and nucleic acid
species were resolved on a polyethylenimine (PEI)
cellulose TLC plate.
(B) WspR, DncV, or cGAS products labeled with
a-32P-GTP were digested with nuclease P1 or
snake venom phosphodiesterase (SVPD) and
resolved on a PEI cellulose TLC plate.linkages (Pino et al., 2008), suggesting that the cGAS product
contains at least one 30-50 phosphodiester linkage (Figure 3B).
Nuclease P1 digestion is incomplete, given that it does not
lead to the generation of GMP, in contrast to what is observed
upon treatment of the DncV product with nuclease P1 (Fig-
ure 3B). As a control, digestion of the cGAS or DncV products
with snake venom phosphodiesterase, which cleaves both
20-50 and 30-50 phosphodiester linkages (Pino et al., 2008), led
to complete digestion (Figure 3B). Altogether, these results
suggest that the cGAS product might also contain a 20-50 phos-
phodiester linkage.
To identify the nature of the cGAS product and, in particular,
ascertain the regiochemistry of the phosphodiester linkages,
we analyzed the cGAS product by nuclear magnetic resonance
(NMR) spectroscopy (Figures 4A and S4). These results indicate
that the product of cGAS is a noncanonical CDN containing a
single 20-50 phosphodiester linkage and that its chemical struc-
ture is assigned as cyclic [G(20-50)pA(30-50)p] (Figure 4B; see
Extended Discussion). This second messenger appears to be a
robust activator of STING. A recently published crystallographic
and enzymatic study of cGAS independently identified this non-
canonical CDN as the product of cGAS (Gao et al., 2013) but did
not address its unique signaling properties. Our results demon-
strating the unique ability of cyclic [G(20-50)pA(30-50)p] to stimu-
late diverse hSTING alleles may explain why cGAS synthesizes
this unusual molecule. Although the bacterial cGAMP synthase
DncV is also a distant homolog of OAS1 and cGAS (Davies
et al., 2012), our IFNb-luciferase reporter and TLC data strongly
suggest that DncV produces a canonical CDN with two 30-50
linkages (Figure 4B). It remains to be determined whether any
bacterial enzymes produce noncanonical CDNs or whether non-
canonical CDNs are unique to mammals.
We identified the R231A mutant of mSTING after a thorough
site-directed mutagenesis of STING (Burdette et al., 2011). We
were surprised to discover that the corresponding arginine
(R232) is a site of natural polymorphism in hSTING. It is
tempting to speculate that the R232H variant of hSTING may
confer a selective advantage by reducing responses to bacte-
rial CDNs while still retaining responsiveness to endogenous
noncanonical CDNs produced by cGAS in response to viral
dsDNA. Indeed, although the production of type I IFNs is essen-1358 Cell Reports 3, 1355–1361, May 30, 2013 ª2013 The Authorstial for the control of most viruses, type I
IFNs have often been found to be detri-
mental in the response to bacterial infec-
tions (Monroe et al., 2010). It is not yetclear why the R231A and R232H STING variants can be stimu-
lated by the noncanonical CDN and not by the canonical CDNs.
An explanation awaits high-resolution structures of these vari-
ants bound to cyclic [G(20-50)pA(30-50)p].
CDNshavebeenproposed tobeuseful as vaccine adjuvants or
immunotherapeutics (Chen et al., 2010). In addition, a synthetic
STING activator, DMXAA, has been tested in human clinical trials
as a chemotherapeutic agent. DMXAA was not found to be
effective in humans, most likely because it is unable to stimulate
hSTING (Conlon et al., 2013). In this context, our results may be
significant because they suggest that noncanonical 20-50 linked
CDNsmight have clinical value as potent pan-agonists of diverse
STING variants, including those variants that respond poorly to
canonical CDNs or DMXAA.
EXPERIMENTAL PROCEDURES
Mice and Cell Lines
THP-1 cells were grown in RPMI 1640 supplemented with 10% fetal bovine
serum (FBS), penicillin-streptomycin, and L-glutamine. HEK 293T cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% FBS, penicillin-streptomycin, and L-glutamine. GP2 retroviral packaging
cell lines were maintained in DMEM supplemented with 10% FBS, penicillin-
streptomycin, and L-glutamine. Animal protocols were approved by the
University of California, Berkeley, Animal Care and Use Committee.
STING Knockdown
Knockdown of hSTING (clone ID NM_198282.1-901s1c1) was achieved with
pLKO.1 (The RNAi Consortium). The sequence for the knockdown of hSTING
is 50-GCA GAG CTA TTT CCT TCC ACA, which corresponds to 50-CCG GGC
AGA GCT ATT TCC TTC CAC ACT CGA GTG TGG AAG GAA ATA GCT CTG
CTT TTT G forward oligo and 50-AAT TCA AAA AGC AGA GCT ATT TCC
TTCCACACTCGAGTG TGGAAGGAAATAGCTCTGC reverse oligo. Oligos
were annealed and cloned into AgeI and EcoRI digested pLKO.1 (Addgene)
and retrovirally transduced into THP-1 cells in parallel with scramble small
hairpin RNA (shRNA) control constructs. Stable cell lines were selected with
puromycin. THP-1 cells were differentiated with 1 mg/ml PMA for 24 hr. Cells
were allowed to rest for 24 hr and then restimulated for 6 hr with the indicated
ligands. IFNb induction was measured by quantitative RT-PCR (qRT-PCR) as
described below.
Cell Stimulation and Reagents
Bone marrow macrophages and HEK 293T cells were stimulated with
Lipofectamine 2000 (Invitrogen). Unless otherwise specified, cdG, cdA,
poly(I:C), and vaccinia virus 70-mer DNA were prepared as described
Figure 4. cGAS Produces a Cyclic Dinucle-
otide Containing a 20-50 Phosphodiester
Linkage
(A) 1H-31P HMBC of HPLC-purified cGAS product
acquired at 600 MHz and 50C. Critical through-
bond correlations for the phosphodiester bonds
are indicated. An NMR-elucidated structure of the
cGAS product is also shown.
(B) Chemical structures of canonical cGAMP,
cyclic [G(30-50)pA(30-50)p] (left), and noncanonical
cGAMP, cyclic [G(20-50)pA(30-50)p] (right) are
shown.
See also Figure S4.previously (Burdette et al., 2011) and used at similar concentrations. Sendai vi-
rus was purchased from Charles River Laboratories. cGAMP was synthesized
as previously described (Kellenberger et al., 2013).
Cloning, Mutagenesis, and Plasmids
The THP-1 STING allele was amplified from complementary DNA (cDNA) with
50 hSTING HindIII (50-ATC GAA GCT TCC ACC ATG CCC CAC TCC AGC CTG)
and 30 hSTING NotI (50-ATC GGC GGC CGC TCA GGC ATA GTC AGG CAC
GTC ATA AGG ATA AGA GAA ATC CGT GCG GAG AG). The resulting PCR
product was cloned into pCDNA3 with HindIII-NotI digestion. THP-1 STING
was amplified and cloned into MSCV2.2 with the 30 primer listed above and
50 hSTING XhoI (50-ATC GCT CGA GCC ACC ATG CCC CAC TCC AGC
CTG) and XhoI-NotI digestion. IFNb-luciferase, TK-Renilla, and mSTING plas-
mids were used as previously described (Burdette et al., 2011). Mutations in
hSTING were introduced with a QuikChange Site-Directed Mutagenesis Kit
(Stratagene). cDNA clones corresponding to mouse and human cGAS (MGC
Fully Sequenced Human MB21D1 cDNA: accession, BC108714.1 and clone
ID, 6015929; EST Fully Sequenced Mouse E330016A19Rik cDNA: accession,
BC145653.1 and clone ID, 40130956) were obtained from Open Biosystems
and correspond to those described previously (Sun et al., 2013; Wu et al.,
2013). Mouse cGAS was amplified from cDNA clones with an N-terminal flag
tag with forward oligo 50-mcGAS-KpnI (50-ATC GGG TAC CCC ACC ATG
GAT TAC AAG GAT GAC GAT GAC AAG GAA GAT CCG CGT AGA AGG)Cell Reports 3, 1355–136and reverse oligo 30-mcGAS-NotI (50-ATC GGC
GGC CGC TCA AAG CTT GTC AAA AAT TGG).
Likewise, hcGAS was amplified with forward oligo
50-hcGAS-flag-KpnI (50-ATC GGG TAC CCC ACC
ATGGAT TACAAGGATGACGATGACAAGCAG
CCT TGG CAC GGA AAG G) and reverse 30-
hcGAS-NotI (50-ATC GGC GGC CGC TCA AAA
TTC ATC AAA AAC TGG AAA C). Both PCR prod-
ucts were cloned into pcDNA3 at KpnI and NotI re-
striction enzyme sites. DncV was amplified with
DncV forward BamHI (50-GCA TGG ATC CGC
CAC CAT GAC TTG GAA CTT TCA CCA G) and
DncV reverse NotI (50-GCA TGC GGC CGC TCA
GCC ACT TAC CAT TGT GCT GC) and cloned
into pCDNA3 with BamHI and NotI. For cloning
into MSCV2.2, DncV was amplified with DncV for-
ward XhoI (50-GCA TCT CGA GCC ACC ATG ACT
TGG AAC TTT CAC CAG) and DncV reverse NotI.
Resulting DNA was cloned into MSCV 2.2
digested with XhoI-NotI. Constructs for bacterial
mcGAS overexpression were constructed as fol-
lows. N-terminal His6-SUMO tag amplified by
PCR with His6 SUMO NcoI (50-TAA TAA GGA
GAT ATA CCA TGG GCA GCA GCC) and His6
SUMO SalI (50-GAA TTC GTC GAC ACC AAT
CTG TTC TCT GTG AGC) off of a pCDF-Duet2
template (a gift from the M. Rape lab) and clonedinto pET28a with NcoI and SalI to make pET28a-H6SUMO. Full-length mcGAS
was PCR amplified from themouse cDNA clone described above with mcGAS
forward SalI (50-GAT GTC GAC ATG GAA GAT CCG CGT AGA AGG ACG) and
mcGAS reverse XhoI (50-ATC CTC GAG TCA AAG CTT GTC AAA AAT TGG
AAA CC) and cloned into pET28a-H6SUMO with SalI and XhoI to make
pET28a-H6SUMO-mcGAS that expresses full-length mcGAS fused to an
N-terminal His6 SUMO tag.
cGAS Product Purification and Structural Characterization
The cGAS product (prepared in vitro as described below) was purified with
reverse-phase high-performance liquid chromatography (HPLC) on an Agilent
1260 Infinity HPLC equipped with an Agilent Polaris C18-A column (5 mm,
250 mm 3 10 mm, 180 A˚). Purification conditions included a 100% to 0%
gradient of solvent A over 20 min at 50C and a flow rate of 5 ml/min, solvent
A being 100 mM ammonium acetate in water at pH 7 and solvent B being
acetonitrile. Purified elution fractions were evaporated multiple times in order
to remove excess ammonia.
Resonance assignments were made with COSY, 1H-13C HSQC, NOESY,
1H-13C HMBC, and 1H-31P HMBC.
The characterization of cGAS product is as follows. 1H NMR (900 MHz,
D2O, 50
C, d): 8.44 (s, 1), 8.42 (s, 1), 8.03 (s, 1), 6.31 (s, 1), 6.09 (d, 1, J =
8 Hz), 5.75 (m, 1), 5.18 (m, 1), 4.93 (s, 1), 4.74, 4.62, 4.59 (d, 1, J = 12 Hz),
4.55 (s, 1), 4.38 (m, 1), 4.33 (d, 1, J = 12 Hz), 4.28 (d, 1, J = 12 Hz); 31P {1H1, May 30, 2013 ª2013 The Authors 1359
decoupled} NMR (600 MHz, D2O, 50
C, d): (all resonances are singlets)0.96,
1.86; HRMS (m/z): [M-H+] calculated for C20H23N10O13P2, 673.0927; found,
673.0909. [M + Na+  2H+] calculated for C20H22N10O13P2Na, 695.0746;
found, 695.0728.
Luciferase Assay
HEK 293T cells were plated in TC-treated 96-well plates at 0.5 3
106 cells ml1. The next day, the cells were transfected with indicated con-
structs, along with IFN-b firefly luciferase and TK-Renilla luciferase reporter
constructs. After stimulation for 6 hr with the indicated ligands, the cells
were lysed in passive lysis buffer (Promega) for 5 min at 25C. The cell lysates
were incubated with firefly luciferase substrate (Biosynth) and the Renilla lucif-
erase substrate coelenterazine (Biotium), and luminescence was measured on
a SpectraMax L Luminescence Microplate Reader (Molecular Devices). The
relative IFNB expression was calculated as firefly luminescence relative to
Renilla luminescence. Statistical differences were calculated with an unpaired
two-tailed Student’s t test with the use of Prism 5.0b software (GraphPad).
In Vitro Cyclic Dinucleotide Synthesis
In vitro DncV reactions were carried out in 20 mM Tris-Cl (pH 8), 20 mM
Mg(OAc)2, 10% glycerol, and 1 mM dithiothreitol, 0.1 mg/ml BSA. Reactions
contained 250 mM GTP and 250 mM ATP or 125 mM GTP and 125 mM ATP,
as indicated in the figures. In addition, 33 nM a-32P-GTP (3,000 Ci/mmol, Per-
kinElmer) or 33 nM a-32P-ATP (3,000 Ci/mmol, PerkinElmer) was included in
reaction where indicated. Reactions were started by the addition of 1 mM
purified DncV protein. In vitro cGAS reactions were carried out in 40 mM
Tris-Cl (pH 7.5), 100 mM NaCl, and 10 mM MgCl2. Cold nucleotide and
a-32P-GTP was at the same concentrations as in DncV reactions. Reactions
were started by the addition of 200 nMpurified cGAS.Where indicated, herring
testes DNA (Sigma-Aldrich) was added to reactions at a final concentration of
0.1 mg/ml. WspR reactions were performed as described previously (Burdette
et al., 2011). Reactions were incubated for 1 hr at 37C, boiled for 5 min at
95C, and spun for 10 min at 13,000 rpm. Reactions were removed and mixed
1:5 with TLC running buffer (1:1.5 [v/v] saturated NH4SO4 and 1.5 M KH2PO4
[pH 3.6]) and spotted on polyethylenimine cellulose TLC plate (Sigma-Aldrich).
Following solvent migration, the TLC plate was exposed to a phosphorimager
screen and imaged with a Typhoon scanner. For in vitro product transfection
into HEK 293T cells, reactions were scaled up, radiolabeled nucleotide was
omitted, and the concentration of ATP and GTP was increased to 2 mM.
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